Connect with us

Politics

Congressional Lawmakers Have Little To Say About Decriminalizing Psychedelics Following Denver Victory

Published

on

Last week, Denver voters approved an initiative to decriminalize the use, possession and production of psilocybin—the active ingredient in “magic mushrooms” or “shrooms.” And while they are the first in the nation to do so, other states like Oregon and California are also considering putting ballot measures on psychedelics up for a vote in 2020.

But as states are beginning to move toward psilocybin decriminalization, don’t expect the issue to garner the same level of attention in Washington, D.C. that cannabis is currently enjoying—at least not yet. Legislators on Capitol Hill who either come from a state considering psychedelics legislation or have a history of championing marijuana reform—another federal Schedule I substance—had no comment on the issue when asked over the past week.

Sen. Rand Paul (R-KY), a longtime supporter of cannabis reform legislation, was willing to answer questions about what it will take for a marijuana banking bill to pass the Senate, but when asked by Marijuana Moment if states’ rights apply to psilocybin, the senator demurred.

“I don’t, I don’t have a comment on that,” he said, picking up his pace and hurrying down the hall in Dirksen Senate Office Building.

Rep. Diana DeGette (D-CO), who represents Denver, has filed several bills aimed at protecting state cannabis laws from federal intervention following Colorado voters’ approval of legalization in 2012. But her office did not respond to several queries about how the congresswoman voted on the local psilocybin ballot measure last week or what actions she is prepared to take to support it at the federal level.

Meanwhile, Sen. Ron Wyden (D-OR), whose state may put a psilocybin measure on the ballot in 2020, was somewhat aware of the issue but said his office hasn’t considered it deeply.

“As you know, there have been a host of areas where, when the federal government has dragged its feet, the states have moved,” Wyden said.

The senator then directed Marijuana Moment to a health policy aide, who in turn referred to another staffer in the senator’s office who handles cannabis issues, who ultimately said it was an issue they haven’t looked into.

Sen. Jeff Merkley (D-OR) and Reps. Lou Correa (D-CA), Ed Perlmutter (D-CO) and Conor Lamb (D-PA), who have all introduced or cosponsored cannabis legislation, and most of whom come from states considering psilocybin reform, all said they did not know enough about the issue to comment.

Lamb, who has signed onto bills calling for more research into cannabis’s potential medical benefits for military veterans, admitted he didn’t know what psilocybin was.

And Correa, who is the chief sponsor of the same veterans legislation, said, “I don’t know what a mushroom looks like—if it’s big, tall or what.”

Activists in Correa’s home state of California are preparing to place a psilocybin decriminalization measure on the state’s general election ballot next year.

The reluctant response isn’t surprising to advocates. Jag Davies of the Drug Policy Alliance, a group that advocates for the decriminalization of all drugs, including marijuana and psilocybin, says that cannabis is by far the most well-known Schedule I substance among politicians.

“That shows right there how different [psilocybin] is from marijuana, where it isn’t… a name people are familiar with,” says Davies.

And many D.C.-based cannabis advocacy groups also do not have plans to incorporate mushrooms into their daily lobbying agenda.

“We have marijuana on the door, not drug,” Justin Strekal of NORML told Marijuana Moment.

Part of the reason for this, especially among advocates, is the impact level. Exponentially more Americans are arrested every year for cannabis possession than for mushrooms. According to the Denver district attorney’s office, only 11 psilocybin cases went to trial there over the past three years. Conversely, in Colorado the year before marijuana became legal, more than 12,000 people were arrested on cannabis-related charges.

Davies says singling out specific, smaller-impact drugs like psilocybin is a mistake that results in the lack of attention given to the issue on the federal level. Advocates feel that instead of trying to tackle the issue piecemeal, states and municipalities trying to end drug prohibition should take a holistic view of decriminalization, as the Colorado legislature has done in passing a bill that decriminalizes single possession of a Schedule I or Schedule II drug—which includes psilocybin. That bill is now headed to the Gov. Jared Polis (D), who is expected to sign it.

Most advocates agree, though, that psilocybin likely would not have been decriminalized had cannabis not already paved the way. And even so, it wasn’t until multiple states legalized marijuana for recreational use that Congress began to take cannabis legislation seriously. When Barack Obama ran for president in 2008, for example, his campaign took pains to clarify that he didn’t even support decriminalizing cannabis; but in 2019, Democratic presidential hopefuls are practically tripping over each other to show greater support for legalizing marijuana outright.

For most politicians on Capitol Hill, cannabis is where their focus is going to stay for the foreseeable future.

“We’ve spent years setting the table for the blueprint, dealing with cannabis legalization,” says long-time cannabis advocate Rep. Earl Blumenauer (D-OR), who released a ‘blueprint’ detailing the path toward comprehensive cannabis legalization on the federal level last year.

“I’m resisting the siren call of being involved with each thing that comes down the path,” he said when Marijuana Moment asked whether he would endorse the proposed psilocybin measure that could appear on the ballot in his home state of Oregon next year.

But even while there appear to be no members of Congress who are currently ready to actively champion broader drug policy reform concerning psychedelics, some are keeping an open mind on the issue.

“Let me tell you how I came to the conclusion that veterans needed to be treated with cannabis: they came to me,” said Correa, who has since led the charge to expand veterans-focused marijuana research.

“I think [also considering psilocybin research for veterans] is a possibility,” the congressman added. “I think we need to look at other alternatives to treating patients, to treating veterans, other than opioids.”

Denver Psilocybin Decriminalization Activist Pushes Back Against Michael Pollan’s Criticism

Photo courtesy of Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Natalie Fertig is a freelance journalist in Washington, D.C. covering cannabis policy. She hails originally from the Pacific Northwest and is a graduate of CUNY Newmark J-School.

Politics

Kentucky GOP Congressman Touts ‘High Hemp IQ’ Of His Constituents

Published

on

Rep. James Comer (R-KY) says that he proved his political advisors wrong when he decided to champion hemp legalization.

When he served as Kentucky’s Agriculture Commissioner before joining Congress and first contemplated “making hemp a reality,” he was told that people would conflate the crop with marijuana and he’d face a backlash, Comer said during an interview that aired this week.

“They said the people of Kentucky will never know the difference. They’ll think you’re talking about marijuana and you’re done,” he said during the Kentucky Educational Television appearance. “You can’t be a Republican and do this.”

“But people in Kentucky are smarter than some people give us credit for, and the people in Kentucky knew the history of hemp,” he said, noting that his own grandparents cultivated the crop.

“We have a high hemp IQ in Kentucky, and people across America are now learning the difference between hemp and marijuana.”

One of the areas that Comer said he hopes to see expanded is the use of hemp fibers to create products such as furniture and car parts. He mentioned one example of a Kentucky company that’s creating hardwood flooring out of hemp, and House Agriculture Committee Chair Collin Peterson (D-MN) is going to tour that facility with him soon.

Shortly before becoming the panel’s chair, Peterson said he was considering growing hemp on his own farm.

Most of the existing hemp facilities in Kentucky are producing CBD oil, which Comer said he also takes to treat minor pain.

While hemp and its derivatives were federally legalized under the 2018 Farm Bill, businesses are still awaiting guidelines from the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA). And that regulatory uncertainty has led some financial institutions to deny credit lines to hemp companies.

To that end, Comer said he and Senate Majority Leader Mitch McConnell (R-KY) are working closely to resolve the problem. That includes pushing for the Secure And Fair Enforcement (SAFE) Banking Act, which would protect banks that service state-legal cannabis businesses from being penalized by federal financial regulators.

“We teamed up with the marijuana people in the states,” Comer said.

Watch Comer’s hemp comments, starting around 5:30 into the video below:

“They’ve legalized marijuana. They’re selling marijuana. They’re not allowed to deposit the cash. They’re not allowed to take credit card transactions at those marijuana stores,” he said. “We have worked with them to try to create a system where you can have financial transparency, and that bill is making its way through Congress now.”

The SAFE Banking Act was approved by the House Financial Services Committee in March. And on Tuesday, the Senate Banking Committee took advocates by surprise after it announced that it would hold a hearing on marijuana banking issues next week, with just days left before the August recess.

Separately, the Senate Agriculture Committee will meet to discuss hemp production two days later.

McConnell has been an especially vocal advocate for hemp and CBD. For example, he led the head of USDA on a tour of a Kentucky hemp facility that produces CBD oil earlier this month.

Comer also claimed in the new interview that large pharmaceutical companies feel threatened by hemp-derived CBD as more consumers gravitate toward it as a “natural supplement” that could be a substitute for prescription painkillers.

“Now what you are having up here in Washington as we speak, the big drug companies are like, ‘Wow, people are buying this CBD oil and not buying our drug,'” the congressman said. “So they’re demanding that the FDA regulate it.”

He and McConnell are working to “keep the FDA off the backs of people,” Comer said.

While former FDA Commissioner Scott Gottlieb stressed that creating a regulatory pathway that allows for the lawful marketing of CBD as a food item or dietary supplement would take years without congressional action, the agency recently said that it is speeding up the rulemaking process and will issue a progress report by early fall.

USDA similarly recognized the intense interest from lawmakers and stakeholders in developing regulations for the crop, and it plans to issue an interim final rule for the crop in August.

Senate Schedules Second Cannabis Hearing For Next Week

Photo courtesy of KET.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Psychedelics Decriminalization Moves Forward In Cities Around The U.S.

Published

on

Activists in Berkeley, California and Port Townsend, Washington took steps this week to get psilocybin mushrooms and other psychedelics decriminalized, following in the footsteps of successful similar efforts in Denver and Oakland.

In Berkeley, a decriminalization resolution advanced in a City Council committee on Wednesday, and organizers in Port Townsend spoke about their proposal at a county public health board meeting on Thursday, with plans to formally present it to the City and County Council.

The Berkeley measure would prohibit city departments and law enforcement from using any funds to enforce laws against possession, propagation and consumption of psychedelics by individuals 21 or older. Members of the City Council Public Safety committee unanimously voted to send the resolution to the body’s Public Health Committee for further consideration.

If that panel approves the measure, the full Council will schedule a hearing and vote on final passage. Decriminalize Nature, the group behind this resolution as well as the successful passage of neighboring Oakland’s psychedelics decriminalization effort last month, said they hope the Council will act on the measure by early November.

Separately, activists in Port Townsend announced that they delivered a speech about their psychedelics decriminalization proposal during a meeting of the Jefferson County Board of Health.

Beyond prohibiting the use of government funds to criminalize adults for using and possessing the substances, the local Washington resolution also calls on the city administrator to “instruct the City’s state and federal lobbyists to work in support of decriminalizing all Entheogenic Plants and plant-based compounds that are listed on the Federal Controlled Substances Schedule 1.”

“We are overwhelmed by the support of our community. Our group of supporters filled up half the audience,” the Port Townsend Psychedelic Society said in an Instagram post. “We are currently making plans to speak with the county health officer to talk about next steps in presenting in front of city and county council.”

Alex Williams, who is leading the decriminalization effort in Berkeley, told Marijuana Moment that Wednesday’s Council committee meeting there “went better than I had anticipated” and that he feels “there is an excellent chance of the resolution passing.”

Watch the Berkeley Public Safety Committee discuss psychedelics, starting at about 42:00:

While Williams said two members of the committee seemed to be under the impression that the resolution is singularly geared toward recreational use and meant to “capitalize on a new market,” Decriminalize Nature plans to address those misconceptions, emphasizing that the measure would not provide for commercial manufacturing or sales and that “this process is very important to allowing safe, equitable access to marginalized communities.”

“It is essential that entheogenic substances be treats as sacred spiritual practices and healers,” he added.

The resolution defines entheogenic substances as “plants and natural sources such as mushrooms, cacti, iboga containing plants and/or extracted combinations of plants similar to ayahuasca; and limited to those containing the following types of compounds: indoleamines, tryptamines, phenethylamines.”

Two Councilmembers, Rigel Robinson and Cheryl Davila, are sponsoring the measure.

“You can imagine a day where, years from now, doctors working with patients with serious depression or veterans dealing with PTSD could actually offer them a more realistic and comprehensive suite of potential treatments, which may include some of these plants as the research over the last several decades has indicated,” Robinson said at the meeting.

While Berkeley might seem like an obvious target for psychedelics reform given the city’s decades-long close association with counterculture, the movement to remove criminal penalties is gaining steam nationally. Decriminalize Nature is maintaining a map of jurisdictions throughout the country where activists have expressed interest in pursuing a similar model.

Also this week, a resident spoke at a Columbia, Missouri City Council meeting, asking the body to consider a resolution to decriminalize psychedelics. At least one councilmember expressed interest in following through, and he called the therapeutic potential of the natural substances “very promising.”

Individuals from nearly 100 cities have reached out to the organization for assistance advancing their own decriminalization efforts.

Voters in Denver kicked things off by approving the nation’s first-ever ballot measure to decriminalize psilocybin mushrooms in May.

Activists are currently pursuing efforts to place psilocybin-focused measures on statewide ballots in California and Oregon for next year.

More Than 100 Marijuana Businesses Urge Congress To Include Social Equity In Legalization

Photo courtesy of Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Top Democratic Party Leader Flops With Attempted Joke About Trump Smoking Hemp

Published

on

The chairman of the Democratic National Committee (DNC) apparently thinks that hemp gets you high—and that getting high makes you dumb.

In an attempted dig at President Donald Trump, who said last week that farmers struggling amid a trade war were “over the hump,” DNC Chair Tom Perez said he thought the president “was smoking some hemp when he said they were over the hump.”

“If you smoke some hemp, I guess that would stimulate certain farm economies here,” he added during his remarks at a press conference in Wisconsin.

Watch Perez’s hemp comment at about 6:45 into the video below:

Because hemp contains only trace amounts of THC, the main psychoactive ingredient in marijuana, it wouldn’t get you high, as Perez implied. But legalization advocates say it’s especially problematic that a party leader is treating marijuana as a laughing matter in the first place.

“I would need to be smoking something a hell of a lot stronger than hemp to find Tom Perez’s weak attempt at a marijuana joke funny,” Erik Altieri, executive director of NORML, told Marijuana Moment.

“At a time when over 600,000 overwhelmingly black and brown Americans are still being arrested every year for simple possession, our failed and racist prohibition is no laughing matter,” he said. “While we have made great progress in winning elected officials nationwide to our cause, Perez illustrated that we have a lot of work left to do when it comes educating them about the issue and still a bit of a road to go down before we can stop dealing with dad jokes and bad weed puns.”

Don Murphy, director of federal policies for the Marijuana Policy Project, echoed that point.

“We need more leadership and action at the federal level, not more stupid jokes, puns and inaccurate comments about hemp’s ability to get you high,” he told Marijuana Moment. “Luckily that is something that many of his party’s presidential candidates understand,” he said. “Sadly, Mr. Perez does not.”

Perez’s position on cannabis policy isn’t quite clear, as he’s remained largely silent on the issue. In contrast, many 2020 Democratic presidential candidates are campaigning on broad marijuana reform proposals.

The DNC chair made his attempted hemp quip during a press availability in Milwaukee, where he is meeting donors and coordinating preparation for next year’s Democratic National Convention.

Senate Schedules Second Cannabis Hearing For Next Week

Photo courtesy of Flickr/Gage Skidmore.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!